Adjuvant oral Razoxane (ICRF 159) in resectable colo-rectal cancer.
作者信息
Slevin M L, Harvey V J, Wrigley P F
出版信息
Cancer Chemother Pharmacol. 1983;10(3):228-9. doi: 10.1007/BF00255772.
PMID:6345019
Abstract
摘要
Slevin M L, Harvey V J, Wrigley P F
Cancer Chemother Pharmacol. 1983;10(3):228-9. doi: 10.1007/BF00255772.
Zotero 插件